25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ABOT (Abbott Laboratories Pakistan Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Abbott Laboratories Pakistan Ltd together

I guess you are interested in Abbott Laboratories Pakistan Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Abbott Laboratories Pakistan Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Abbott Laboratories Pakistan Ltd’s Price Targets

I'm going to help you getting a better view of Abbott Laboratories Pakistan Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Abbott Laboratories Pakistan Ltd

I send you an email if I find something interesting about Abbott Laboratories Pakistan Ltd.

1. Quick Overview

1.1. Quick analysis of Abbott Laboratories Pakistan Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Abbott Laboratories Pakistan Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₨0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
₨249.42
Expected worth in 1 year
₨296.21
How sure are you?
77.3%

+ What do you gain per year?

Total Gains per Share
₨46.82
Return On Investment
4.8%

For what price can you sell your share?

Current Price per Share
₨972.05
Expected price per share
₨793.14 - ₨1,075
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abbott Laboratories Pakistan Ltd (5 min.)




Live pricePrice per Share (EOD)
₨972.05
Intrinsic Value Per Share
₨-263.92 - ₨-314.76
Total Value Per Share
₨-14.50 - ₨-65.33

2.2. Growth of Abbott Laboratories Pakistan Ltd (5 min.)




Is Abbott Laboratories Pakistan Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$85.4m$62.1m$17.5m22.0%

How much money is Abbott Laboratories Pakistan Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.6m$1.7m$2.9m62.4%
Net Profit Margin7.6%3.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Abbott Laboratories Pakistan Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  


Richest
#22 / 30

Most Revenue
#19 / 30

Most Profit
#17 / 30
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abbott Laboratories Pakistan Ltd?

Welcome investor! Abbott Laboratories Pakistan Ltd's management wants to use your money to grow the business. In return you get a share of Abbott Laboratories Pakistan Ltd.

First you should know what it really means to hold a share of Abbott Laboratories Pakistan Ltd. And how you can make/lose money.

Speculation

The Price per Share of Abbott Laboratories Pakistan Ltd is ₨972.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abbott Laboratories Pakistan Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abbott Laboratories Pakistan Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₨249.42. Based on the TTM, the Book Value Change Per Share is ₨11.70 per quarter. Based on the YOY, the Book Value Change Per Share is ₨7.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₨0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abbott Laboratories Pakistan Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.060.0%0.050.0%0.020.0%0.030.0%0.040.0%0.030.0%
Usd Book Value Change Per Share0.020.0%0.040.0%0.030.0%0.020.0%0.020.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.020.0%0.010.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.020.0%0.040.0%0.050.0%0.030.0%0.040.0%0.060.0%
Usd Price Per Share3.85-3.36-1.45-2.22-2.36-2.00-
Price to Earnings Ratio16.84-19.91-317.59-115.53-74.67-60.93-
Price-to-Total Gains Ratio154.70-97.52-100.83-49.46-31.58-37.76-
Price to Book Ratio4.41-4.09-2.27-3.07-3.68-3.17-
Price-to-Total Gains Ratio154.70-97.52-100.83-49.46-31.58-37.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.402175
Number of shares293
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share0.040.02
Usd Total Gains Per Share0.040.04
Gains per Quarter (293 shares)12.0011.00
Gains per Year (293 shares)48.0143.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104838212334
209686424678
301441346468122
401921828591166
50240230106114210
60288278127137254
70336326148160298
80384374169183342
90432422191205386
100480470212228430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%20.02.00.090.9%20.02.00.090.9%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%13.07.00.065.0%15.07.00.068.2%15.07.00.068.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%15.05.00.075.0%17.05.00.077.3%17.05.00.077.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Abbott Laboratories Pakistan Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.08811.696-39%7.366-4%6.421+10%5.561+27%11.337-37%
Book Value Per Share--249.423232.675+7%181.397+38%199.865+25%184.199+35%158.351+58%
Current Ratio--1.9481.840+6%1.389+40%1.589+23%1.701+15%1.708+14%
Debt To Asset Ratio--0.3790.394-4%0.519-27%0.467-19%0.448-15%0.435-13%
Debt To Equity Ratio--0.6110.651-6%1.100-44%0.906-33%0.834-27%0.791-23%
Dividend Per Share--0.0250.009+188%6.140-100%2.990-99%5.163-100%4.696-99%
Enterprise Value--92794702305.70079144969899.710+17%21237389417.770+337%44184620385.085+110%50777394229.413+83%48819805619.698+90%
Eps--16.34013.573+20%5.107+220%8.024+104%10.474+56%8.947+83%
Ev To Sales Ratio--1.3371.129+18%0.363+268%0.715+87%1.033+30%1.022+31%
Free Cash Flow Per Share--1.6156.469-75%-5.216+423%-1.847+214%4.833-67%5.449-70%
Free Cash Flow To Equity Per Share--1.6156.469-75%-5.216+423%-1.847+214%4.833-67%5.449-70%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---314.758----------
Intrinsic Value_10Y_min---263.924----------
Intrinsic Value_1Y_max---10.900----------
Intrinsic Value_1Y_min---10.694----------
Intrinsic Value_3Y_max---48.480----------
Intrinsic Value_3Y_min---45.966----------
Intrinsic Value_5Y_max---105.027----------
Intrinsic Value_5Y_min---96.129----------
Market Cap--107724597305.70093896669149.710+15%40494991417.770+166%60993810385.085+77%65430960079.413+65%55340713105.334+95%
Net Profit Margin--0.0920.076+21%0.032+193%0.049+88%0.084+10%0.078+18%
Operating Margin----0%-0%-0%0.022-100%0.044-100%
Operating Ratio--1.5161.563-3%1.721-12%1.627-7%1.562-3%1.571-4%
Pb Ratio3.897-13%4.4124.088+8%2.271+94%3.072+44%3.684+20%3.170+39%
Pe Ratio14.872-13%16.83519.909-15%317.594-95%115.526-85%74.671-77%60.927-72%
Price Per Share972.050-13%1100.350959.105+15%413.635+166%633.758+74%674.786+63%570.430+93%
Price To Free Cash Flow Ratio150.486-13%170.349174.690-2%-12.889+108%39.847+328%31.008+449%25.571+566%
Price To Total Gains Ratio136.659-13%154.69697.516+59%100.829+53%49.458+213%31.584+390%37.761+310%
Quick Ratio--0.2690.241+12%0.134+102%0.243+11%0.330-18%0.289-7%
Return On Assets--0.0410.035+16%0.014+196%0.021+94%0.033+23%0.030+34%
Return On Equity--0.0660.058+14%0.025+163%0.036+81%0.057+15%0.052+26%
Total Gains Per Share--7.11311.704-39%13.506-47%9.411-24%10.725-34%16.033-56%
Usd Book Value--85465037.00079726424.750+7%62155879.625+38%67108302.917+27%62290722.375+37%58995775.160+45%
Usd Book Value Change Per Share--0.0250.041-39%0.026-4%0.022+10%0.019+27%0.040-37%
Usd Book Value Per Share--0.8730.814+7%0.635+38%0.700+25%0.645+35%0.554+58%
Usd Dividend Per Share--0.0000.000+188%0.021-100%0.010-99%0.018-100%0.016-99%
Usd Enterprise Value--324781458.070277007394.649+17%74330862.962+337%154646171.348+110%177720879.803+83%170869319.669+90%
Usd Eps--0.0570.048+20%0.018+220%0.028+104%0.037+56%0.031+83%
Usd Free Cash Flow--553329.0002216480.875-75%-1787380.875+423%-498914.500+190%1736467.425-68%1304154.460-58%
Usd Free Cash Flow Per Share--0.0060.023-75%-0.018+423%-0.006+214%0.017-67%0.019-70%
Usd Free Cash Flow To Equity Per Share--0.0060.023-75%-0.018+423%-0.006+214%0.017-67%0.019-70%
Usd Market Cap--377036090.570328638342.024+15%141732469.962+166%213478336.348+77%229008360.278+65%193692495.869+95%
Usd Price Per Share3.402-13%3.8513.357+15%1.448+166%2.218+74%2.362+63%1.997+93%
Usd Profit--5598855.5004650752.750+20%1750050.750+220%2649217.958+111%3528805.000+59%3125780.280+79%
Usd Revenue--60712578.50060807880.0000%50485995.000+20%51585268.875+18%45224668.650+34%41530166.440+46%
Usd Total Gains Per Share--0.0250.041-39%0.047-47%0.033-24%0.038-34%0.056-56%
 EOD+4 -2MRQTTM+25 -12YOY+28 -93Y+30 -75Y+24 -1410Y+22 -16

3.3 Fundamental Score

Let's check the fundamental score of Abbott Laboratories Pakistan Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.872
Price to Book Ratio (EOD)Between0-13.897
Net Profit Margin (MRQ)Greater than00.092
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.269
Current Ratio (MRQ)Greater than11.948
Debt to Asset Ratio (MRQ)Less than10.379
Debt to Equity Ratio (MRQ)Less than10.611
Return on Equity (MRQ)Greater than0.150.066
Return on Assets (MRQ)Greater than0.050.041
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Abbott Laboratories Pakistan Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.161
Ma 20Greater thanMa 50960.913
Ma 50Greater thanMa 100970.171
Ma 100Greater thanMa 2001,043.602
OpenGreater thanClose975.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Abbott Laboratories Pakistan Ltd

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Abbott Laboratories Pakistan Ltd earns for each ₨1 of revenue.

  • Above 10% is considered healthy but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 9.2% means that ₨0.09 for each ₨1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 9.2%. The company is making a profit. +1
  • The TTM is 7.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.2%TTM7.6%+1.6%
TTM7.6%YOY3.2%+4.4%
TTM7.6%5Y8.4%-0.8%
5Y8.4%10Y7.8%+0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ9.2%11.4%-2.2%
TTM7.6%10.2%-2.6%
YOY3.2%10.5%-7.3%
3Y4.9%9.4%-4.5%
5Y8.4%12.7%-4.3%
10Y7.8%11.6%-3.8%
4.3.1.2. Return on Assets

Shows how efficient Abbott Laboratories Pakistan Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • 4.1% Return on Assets means that Abbott Laboratories Pakistan Ltd generated ₨0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 4.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.1%TTM3.5%+0.6%
TTM3.5%YOY1.4%+2.1%
TTM3.5%5Y3.3%+0.2%
5Y3.3%10Y3.0%+0.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%4.9%-0.8%
TTM3.5%4.9%-1.4%
YOY1.4%4.4%-3.0%
3Y2.1%5.2%-3.1%
5Y3.3%4.5%-1.2%
10Y3.0%4.6%-1.6%
4.3.1.3. Return on Equity

Shows how efficient Abbott Laboratories Pakistan Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • 6.6% Return on Equity means Abbott Laboratories Pakistan Ltd generated ₨0.07 for each ₨1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 6.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM5.8%+0.8%
TTM5.8%YOY2.5%+3.3%
TTM5.8%5Y5.7%+0.1%
5Y5.7%10Y5.2%+0.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6%9.6%-3.0%
TTM5.8%9.6%-3.8%
YOY2.5%7.0%-4.5%
3Y3.6%7.6%-4.0%
5Y5.7%7.6%-1.9%
10Y5.2%8.7%-3.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Abbott Laboratories Pakistan Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Abbott Laboratories Pakistan Ltd is operating .

  • Measures how much profit Abbott Laboratories Pakistan Ltd makes for each ₨1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₨0.00  for each ₨1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y4.4%-2.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
TTM-9.6%-9.6%
YOY-8.1%-8.1%
3Y-4.2%-4.2%
5Y2.2%9.0%-6.8%
10Y4.4%10.4%-6.0%
4.3.2.2. Operating Ratio

Measures how efficient Abbott Laboratories Pakistan Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are ₨1.52 for each ₨1 in net sales.

Let's take a look of the Operating Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 1.516. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.563. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.516TTM1.563-0.047
TTM1.563YOY1.721-0.158
TTM1.5635Y1.562+0.001
5Y1.56210Y1.571-0.009
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5161.231+0.285
TTM1.5631.176+0.387
YOY1.7211.220+0.501
3Y1.6271.233+0.394
5Y1.5621.226+0.336
10Y1.5711.211+0.360
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Abbott Laboratories Pakistan Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abbott Laboratories Pakistan Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.95 means the company has ₨1.95 in assets for each ₨1 in short-term debts.

Let's take a look of the Current Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 1.948. The company is able to pay all its short-term debts. +1
  • The TTM is 1.840. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.948TTM1.840+0.108
TTM1.840YOY1.389+0.452
TTM1.8405Y1.701+0.139
5Y1.70110Y1.708-0.007
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9481.933+0.015
TTM1.8401.986-0.146
YOY1.3892.234-0.845
3Y1.5892.088-0.499
5Y1.7012.256-0.555
10Y1.7082.036-0.328
4.4.3.2. Quick Ratio

Measures if Abbott Laboratories Pakistan Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.27 means the company can pay off ₨0.27 for each ₨1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 0.269. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.241. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.269TTM0.241+0.029
TTM0.241YOY0.134+0.107
TTM0.2415Y0.330-0.089
5Y0.33010Y0.289+0.041
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2691.059-0.790
TTM0.2411.109-0.868
YOY0.1341.245-1.111
3Y0.2431.424-1.181
5Y0.3301.642-1.312
10Y0.2891.573-1.284
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Abbott Laboratories Pakistan Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Abbott Laboratories Pakistan Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abbott Laboratories Pakistan Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.38 means that Abbott Laboratories Pakistan Ltd assets are financed with 37.9% credit (debt) and the remaining percentage (100% - 37.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 0.379. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.394. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.394-0.014
TTM0.394YOY0.519-0.126
TTM0.3945Y0.448-0.054
5Y0.44810Y0.435+0.013
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.324+0.055
TTM0.3940.326+0.068
YOY0.5190.336+0.183
3Y0.4670.314+0.153
5Y0.4480.328+0.120
10Y0.4350.338+0.097
4.5.4.2. Debt to Equity Ratio

Measures if Abbott Laboratories Pakistan Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 61.1% means that company has ₨0.61 debt for each ₨1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The MRQ is 0.611. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.651. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.611TTM0.651-0.040
TTM0.651YOY1.100-0.448
TTM0.6515Y0.834-0.182
5Y0.83410Y0.791+0.043
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6110.492+0.119
TTM0.6510.492+0.159
YOY1.1000.547+0.553
3Y0.9060.488+0.418
5Y0.8340.502+0.332
10Y0.7910.528+0.263
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₨1 in earnings Abbott Laboratories Pakistan Ltd generates.

  • Above 15 is considered overpriced but always compare Abbott Laboratories Pakistan Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 16.84 means the investor is paying ₨16.84 for every ₨1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The EOD is 14.872. Based on the earnings, the company is underpriced. +1
  • The MRQ is 16.835. Based on the earnings, the company is fair priced.
  • The TTM is 19.909. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.872MRQ16.835-1.963
MRQ16.835TTM19.909-3.074
TTM19.909YOY317.594-297.685
TTM19.9095Y74.671-54.762
5Y74.67110Y60.927+13.744
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD14.87228.186-13.314
MRQ16.83525.404-8.569
TTM19.90927.573-7.664
YOY317.59422.687+294.907
3Y115.52623.741+91.785
5Y74.67128.695+45.976
10Y60.92728.267+32.660
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The EOD is 150.486. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 170.349. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 174.690. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD150.486MRQ170.349-19.863
MRQ170.349TTM174.690-4.341
TTM174.690YOY-12.889+187.579
TTM174.6905Y31.008+143.682
5Y31.00810Y25.571+5.437
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD150.48625.179+125.307
MRQ170.34922.139+148.210
TTM174.69017.570+157.120
YOY-12.88927.354-40.243
3Y39.84736.662+3.185
5Y31.00836.120-5.112
10Y25.57130.424-4.853
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Abbott Laboratories Pakistan Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 4.41 means the investor is paying ₨4.41 for each ₨1 in book value.

Let's take a look of the Price to Book Ratio trends of Abbott Laboratories Pakistan Ltd:

  • The EOD is 3.897. Based on the equity, the company is fair priced.
  • The MRQ is 4.412. Based on the equity, the company is fair priced.
  • The TTM is 4.088. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.897MRQ4.412-0.514
MRQ4.412TTM4.088+0.323
TTM4.088YOY2.271+1.817
TTM4.0885Y3.684+0.405
5Y3.68410Y3.170+0.514
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD3.8973.789+0.108
MRQ4.4124.187+0.225
TTM4.0884.216-0.128
YOY2.2713.209-0.938
3Y3.0723.242-0.170
5Y3.6843.625+0.059
10Y3.1703.591-0.421
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in PKR. All numbers in thousands.

Summary
Total Assets39,348,477
Total Liabilities14,929,895
Total Stockholder Equity24,418,582
 As reported
Total Liabilities 14,929,895
Total Stockholder Equity+ 24,418,582
Total Assets = 39,348,477

Assets

Total Assets39,348,477
Total Current Assets24,784,465
Long-term Assets14,564,012
Total Current Assets
Cash And Cash Equivalents 6,594,125
Net Receivables 3,425,879
Inventory 11,787,789
Total Current Assets  (as reported)24,784,465
Total Current Assets  (calculated)21,807,793
+/- 2,976,672
Long-term Assets
Property Plant Equipment 14,401,709
Long-term Assets  (as reported)14,564,012
Long-term Assets  (calculated)14,401,709
+/- 162,303

Liabilities & Shareholders' Equity

Total Current Liabilities12,720,632
Long-term Liabilities2,209,263
Total Stockholder Equity24,418,582
Total Current Liabilities
Accounts payable 5,634,985
Total Current Liabilities  (as reported)12,720,632
Total Current Liabilities  (calculated)5,634,985
+/- 7,085,647
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt54,267
Long-term Liabilities  (as reported)2,209,263
Long-term Liabilities  (calculated)54,267
+/- 2,154,996
Total Stockholder Equity
Retained Earnings 16,277,400
Total Stockholder Equity (as reported)24,418,582
Total Stockholder Equity (calculated)16,277,400
+/- 8,141,182
Other
Capital Stock979,003
Common Stock Shares Outstanding 97,900
Net Invested Capital 24,418,582
Net Working Capital 12,063,833
Property Plant and Equipment Gross 14,401,709



6.2. Balance Sheets Structured

Currency in PKR. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
20,343,029
21,023,258
21,214,352
20,752,680
22,559,891
24,086,390
23,383,591
24,915,744
27,581,810
29,627,116
28,939,470
28,567,747
30,120,544
31,434,281
31,713,233
33,919,795
36,540,171
36,274,132
38,989,240
36,693,445
36,108,882
35,804,682
37,318,394
37,651,158
39,348,477
39,348,47737,651,15837,318,39435,804,68236,108,88236,693,44538,989,24036,274,13236,540,17133,919,79531,713,23331,434,28130,120,54428,567,74728,939,47029,627,11627,581,81024,915,74423,383,59124,086,39022,559,89120,752,68021,214,35221,023,25820,343,029
   > Total Current Assets 
12,747,445
13,081,052
13,113,308
12,337,862
14,182,262
15,700,099
15,017,334
15,701,737
18,303,547
20,248,623
19,150,769
18,432,447
19,679,414
20,587,546
20,403,133
21,828,890
24,149,505
23,489,202
26,024,231
23,199,218
22,576,124
22,165,505
23,260,057
23,261,662
24,784,465
24,784,46523,261,66223,260,05722,165,50522,576,12423,199,21826,024,23123,489,20224,149,50521,828,89020,403,13320,587,54619,679,41418,432,44719,150,76920,248,62318,303,54715,701,73715,017,33415,700,09914,182,26212,337,86213,113,30813,081,05212,747,445
       Cash And Cash Equivalents 
4,143,740
3,193,986
1,926,902
2,757,519
4,296,632
5,857,475
5,209,212
7,488,881
9,443,359
2,757,943
2,397,952
819,347
1,329,669
2,857,371
1,686,346
7,966,029
6,697,315
3,390,593
3,280,482
5,036,712
2,920,989
3,027,416
3,358,208
6,182,349
6,594,125
6,594,1256,182,3493,358,2083,027,4162,920,9895,036,7123,280,4823,390,5936,697,3157,966,0291,686,3462,857,3711,329,669819,3472,397,9522,757,9439,443,3597,488,8815,209,2125,857,4754,296,6322,757,5191,926,9023,193,9864,143,740
       Short-term Investments 
0
0
0
0
0
0
0
0
0
8,055,264
6,569,473
7,841,030
8,122,782
6,081,550
5,500,000
830,079
499,143
495,000
495,000
502,822
495,000
495,000
500,064
0
0
00500,064495,000495,000502,822495,000495,000499,143830,0795,500,0006,081,5508,122,7827,841,0306,569,4738,055,264000000000
       Net Receivables 
1,074,297
861,293
869,110
956,430
852,191
826,220
525,828
987,961
927,139
958,767
965,893
1,294,781
1,062,957
1,397,620
1,263,992
1,379,681
1,662,425
1,416,575
1,637,316
1,649,512
2,305,929
2,220,693
2,421,793
3,135,320
3,425,879
3,425,8793,135,3202,421,7932,220,6932,305,9291,649,5121,637,3161,416,5751,662,4251,379,6811,263,9921,397,6201,062,9571,294,781965,893958,767927,139987,961525,828826,220852,191956,430869,110861,2931,074,297
       Inventory 
5,669,879
6,923,514
7,961,819
6,325,537
6,048,691
6,748,797
7,075,573
5,226,008
5,949,808
6,833,225
7,364,246
7,005,588
6,969,582
7,471,861
8,682,852
8,855,976
11,146,618
13,875,407
15,747,767
13,289,535
13,126,599
12,226,628
13,127,031
11,224,134
11,787,789
11,787,78911,224,13413,127,03112,226,62813,126,59913,289,53515,747,76713,875,40711,146,6188,855,9768,682,8527,471,8616,969,5827,005,5887,364,2466,833,2255,949,8085,226,0087,075,5736,748,7976,048,6916,325,5377,961,8196,923,5145,669,879
   > Long-term Assets 
7,595,584
7,942,206
8,101,044
8,414,818
8,377,629
8,386,291
8,366,257
9,214,007
9,278,263
9,378,493
9,788,701
10,135,300
10,441,130
10,846,735
11,310,100
12,090,905
12,390,666
12,784,930
12,965,009
13,494,227
13,532,758
13,639,177
14,058,337
14,389,496
14,564,012
14,564,01214,389,49614,058,33713,639,17713,532,75813,494,22712,965,00912,784,93012,390,66612,090,90511,310,10010,846,73510,441,13010,135,3009,788,7019,378,4939,278,2639,214,0078,366,2578,386,2918,377,6298,414,8188,101,0447,942,2067,595,584
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,277,951
12,674,906
12,852,213
13,375,186
13,411,872
13,511,784
13,926,087
14,252,797
14,401,709
14,401,70914,252,79713,926,08713,511,78413,411,87213,375,18612,852,21312,674,90612,277,9510000000000000000
       Intangible Assets 
0
0
0
78,372
0
0
0
66,255
0
0
0
49,017
0
0
0
26,904
0
0
0
12,678
0
0
0
1,250
0
01,25000012,67800026,90400049,01700066,25500078,372000
       Long-term Assets Other 
7,595,584
7,942,206
8,101,044
8,414,818
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000008,414,8188,101,0447,942,2067,595,584
> Total Liabilities 
7,733,581
8,202,888
8,094,545
7,380,287
9,030,500
9,270,719
9,022,248
9,325,492
12,967,691
13,145,146
13,171,661
11,213,109
13,244,971
14,179,351
15,093,918
16,813,766
19,586,040
19,832,367
22,471,650
18,456,099
16,270,292
15,263,568
14,886,812
13,926,522
14,929,895
14,929,89513,926,52214,886,81215,263,56816,270,29218,456,09922,471,65019,832,36719,586,04016,813,76615,093,91814,179,35113,244,97111,213,10913,171,66113,145,14612,967,6919,325,4929,022,2489,270,7199,030,5007,380,2878,094,5458,202,8887,733,581
   > Total Current Liabilities 
7,260,307
7,647,645
7,539,684
6,842,951
8,469,180
8,656,191
8,353,581
6,833,822
10,486,107
10,981,003
10,958,315
9,343,382
11,344,709
12,129,906
12,946,081
14,607,276
17,473,013
17,605,673
20,151,129
16,835,213
14,560,631
13,469,211
13,120,431
11,660,211
12,720,632
12,720,63211,660,21113,120,43113,469,21114,560,63116,835,21320,151,12917,605,67317,473,01314,607,27612,946,08112,129,90611,344,7099,343,38210,958,31510,981,00310,486,1076,833,8228,353,5818,656,1918,469,1806,842,9517,539,6847,647,6457,260,307
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
15,775
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000015,77500000000000
       Accounts payable 
6,098,405
7,504,358
7,401,421
933,368
7,595,068
5,133,670
5,011,159
2,390,711
7,793,866
5,069,920
4,997,276
3,726,662
4,571,553
9,872,034
5,295,118
6,597,831
10,370,750
10,203,443
12,394,198
9,469,066
9,321,193
8,189,249
7,123,138
4,389,226
5,634,985
5,634,9854,389,2267,123,1388,189,2499,321,1939,469,06612,394,19810,203,44310,370,7506,597,8315,295,1189,872,0344,571,5533,726,6624,997,2765,069,9207,793,8662,390,7115,011,1595,133,6707,595,068933,3687,401,4217,504,3586,098,405
   > Long-term Liabilities 
473,274
555,243
554,861
537,336
561,320
614,528
668,667
2,491,670
2,481,584
2,164,143
2,213,346
1,869,727
1,900,262
2,049,445
2,147,837
2,206,490
2,113,027
2,226,694
2,320,521
1,620,886
1,709,661
1,794,357
1,766,381
2,266,311
2,209,263
2,209,2632,266,3111,766,3811,794,3571,709,6611,620,8862,320,5212,226,6942,113,0272,206,4902,147,8372,049,4451,900,2621,869,7272,213,3462,164,1432,481,5842,491,670668,667614,528561,320537,336554,861555,243473,274
       Capital Lease Obligations Min Short Term Debt
382,888
348,134
400,554
381,139
414,901
436,471
484,145
816,249
875,868
287,843
220,660
227,686
233,123
208,409
240,011
247,287
254,794
177,156
153,864
158,218
163,252
76,011
50,265
52,228
54,267
54,26752,22850,26576,011163,252158,218153,864177,156254,794247,287240,011208,409233,123227,686220,660287,843875,868816,249484,145436,471414,901381,139400,554348,134382,888
> Total Stockholder Equity
12,609,448
12,820,370
13,119,807
13,372,393
13,529,391
14,815,671
14,361,343
15,590,252
14,614,119
16,481,970
15,767,809
17,354,638
16,875,573
17,254,930
16,619,315
17,106,029
16,954,131
16,441,765
16,517,590
18,237,346
19,838,590
20,541,114
22,431,582
23,724,636
24,418,582
24,418,58223,724,63622,431,58220,541,11419,838,59018,237,34616,517,59016,441,76516,954,13117,106,02916,619,31517,254,93016,875,57317,354,63815,767,80916,481,97014,614,11915,590,25214,361,34314,815,67113,529,39113,372,39313,119,80712,820,37012,609,448
   Common Stock0000000000000000000000000
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000



6.3. Balance Sheets

Currency in PKR. All numbers in thousands.




6.4. Cash Flows

Currency in PKR. All numbers in thousands.




6.5. Income Statements

Currency in PKR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in PKR. All numbers in thousands.

Gross Profit (+$)
totalRevenue68,177,197
Cost of Revenue-48,439,489
Gross Profit19,737,70819,737,708
 
Operating Income (+$)
Gross Profit19,737,708
Operating Expense-59,662,673
Operating Income8,514,524-39,924,965
 
Operating Expense (+$)
Research Development81,060
Selling General Administrative5,892,305
Selling And Marketing Expenses0
Operating Expense59,662,6735,973,365
 
Net Interest Income (+$)
Interest Income464,355
Interest Expense-11,739
Other Finance Cost-11,875
Net Interest Income440,741
 
Pretax Income (+$)
Operating Income8,514,524
Net Interest Income440,741
Other Non-Operating Income Expenses0
Income Before Tax (EBT)9,127,5198,514,524
EBIT - interestExpense = -11,739
5,234,233
5,245,972
Interest Expense11,739
Earnings Before Interest and Taxes (EBIT)09,139,258
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax9,127,519
Tax Provision-3,893,286
Net Income From Continuing Ops5,234,2335,234,233
Net Income5,234,233
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-440,741
 

Technical Analysis of Abbott Laboratories Pakistan Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abbott Laboratories Pakistan Ltd. The general trend of Abbott Laboratories Pakistan Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abbott Laboratories Pakistan Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Abbott Laboratories Pakistan Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Abbott Laboratories Pakistan Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,028 < 1,034 < 1,075.

The bearish price targets are: 925.02 > 925.02 > 793.14.

Know someone who trades $ABOT? Share this with them.👇

Abbott Laboratories Pakistan Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Abbott Laboratories Pakistan Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Abbott Laboratories Pakistan Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Abbott Laboratories Pakistan Ltd. The current macd is -1.61643574.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abbott Laboratories Pakistan Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Abbott Laboratories Pakistan Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Abbott Laboratories Pakistan Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Abbott Laboratories Pakistan Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAbbott Laboratories Pakistan Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Abbott Laboratories Pakistan Ltd. The current adx is 14.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Abbott Laboratories Pakistan Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Abbott Laboratories Pakistan Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Abbott Laboratories Pakistan Ltd. The current sar is 1,034.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Abbott Laboratories Pakistan Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Abbott Laboratories Pakistan Ltd. The current rsi is 52.16. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Abbott Laboratories Pakistan Ltd Daily Relative Strength Index (RSI) ChartAbbott Laboratories Pakistan Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Abbott Laboratories Pakistan Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abbott Laboratories Pakistan Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Abbott Laboratories Pakistan Ltd Daily Stochastic Oscillator ChartAbbott Laboratories Pakistan Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Abbott Laboratories Pakistan Ltd. The current cci is 8.69194815.

Abbott Laboratories Pakistan Ltd Daily Commodity Channel Index (CCI) ChartAbbott Laboratories Pakistan Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Abbott Laboratories Pakistan Ltd. The current cmo is 9.63642985.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Abbott Laboratories Pakistan Ltd Daily Chande Momentum Oscillator (CMO) ChartAbbott Laboratories Pakistan Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Abbott Laboratories Pakistan Ltd. The current willr is -56.84529271.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Abbott Laboratories Pakistan Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Abbott Laboratories Pakistan Ltd Daily Williams %R ChartAbbott Laboratories Pakistan Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Abbott Laboratories Pakistan Ltd.

Abbott Laboratories Pakistan Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Abbott Laboratories Pakistan Ltd. The current atr is 31.91.

Abbott Laboratories Pakistan Ltd Daily Average True Range (ATR) ChartAbbott Laboratories Pakistan Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Abbott Laboratories Pakistan Ltd. The current obv is 5,360,166.

Abbott Laboratories Pakistan Ltd Daily On-Balance Volume (OBV) ChartAbbott Laboratories Pakistan Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Abbott Laboratories Pakistan Ltd. The current mfi is 54.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Abbott Laboratories Pakistan Ltd Daily Money Flow Index (MFI) ChartAbbott Laboratories Pakistan Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Abbott Laboratories Pakistan Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Abbott Laboratories Pakistan Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Abbott Laboratories Pakistan Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.161
Ma 20Greater thanMa 50960.913
Ma 50Greater thanMa 100970.171
Ma 100Greater thanMa 2001,043.602
OpenGreater thanClose975.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Abbott Laboratories Pakistan Ltd with someone you think should read this too:
  • Are you bullish or bearish on Abbott Laboratories Pakistan Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abbott Laboratories Pakistan Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Abbott Laboratories Pakistan Ltd

I send you an email if I find something interesting about Abbott Laboratories Pakistan Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Abbott Laboratories Pakistan Ltd.

Receive notifications about Abbott Laboratories Pakistan Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.